Attomarker Launches Acceleration Round to Support Next Phase of Immunology Diagnostics Development Exeter, United Kingdom – Attomarker, a leading UK-based diagnostics company, announced today the commencement of an Acceleration Round to support the next phase of commercial and clinical development of its innovative immunology diagnostics platform. The company specializes in developing multiplex…
